COVID-19 Updates
COVID 19 Resources for Dentists
The Governor’s new proclamation issued May 18, 2020 and the Governor’s medium website provides information for Reducing Restrictions on, and Safe Expansion of, Non-Urgent Medical and Dental Procedures.
The ADA, OSHA, and CDC, have published guidelines for healthcare providers. Here are some additional links. CDC - Strategies to Optimize the Supply of PPE and Equipment
CDC - Clinical Care Guidance for Healthcare Professionals about Coronavirus (COVID-19)
CDC - Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19)
DOH – Resources for Healthcare providers
Provider Relief Fund Now Open for Phase 3
The U.S. Department of Health and Human Services (HHS) has started Phase 3 of the Provider Relief Fund (PRF). Applications are open through Nov. 6, 2020. https://www.hhs.gov/coronavirus/cares-act-provider-relief-fund/for-providers/index.html?language=es#how-to-apply
Phase 3 will impact:
Newly Eligible: Dentists who began practicing Jan. 1 – March 30, 2020.Add-on Payment: All dentists who previously received, rejected or accepted payment from the PRF can submit more information to become eligible for an additional payment.Corrections: All dentists who previously received, rejected or accepted a PRF payment and did not receive approximately 2% of annual revenues from patient care will now receive this amount, plus their Phase 3 allocation. https://success.ada.org/~/media/CPS/Files/COVID/HHS_Provider_Relief_Fund_FAQ.pdf
|
|
|
|
23403 E Mission Ave, Suite 104
Liberty Lake, WA, 99019
Phone: 509-838-0436
Fax: 509-838-5040
|
| SPOKANE DISTRICT DENTAL SOCIETY PROGRAMS |
SDDS November 2019 Newsletter HERE
SDDS September 2019 Newsletter HERE
Interested in partnering with SDDS on a special event, general membership meeting or continuing education program? Email info@spokanedentalsociety.org
2020 - May 2021 Membership Meetings
SDDS Members Only
Program starts at 6pm
Location: Zoom
Contact info@spokanedentalsociety.org
CONTINUING EDUCATION
Opportunity for FREE CE's - See below for details
Here is some helpful information provided by Zimmer for all Clinicians struggling to stay busy and up to date on education and CE. It's meant to be a helpful tool for offices wanting CE and university based education from non-biased well-known speakers. ALL of the CE IS FREE. The link below is for our ON DEMAND ( can be viewed on smart phones, laptops, pads etc) anytime, anywhere. They cover anything from patient acceptance, implant hygiene, to labs, to restorative, to bone grafting techniques and advanced surgical.
Zimmer Biomet On-Demand Web-Based Programs
Dr. Art DiMarco: Local Anesthesia Updates – Playing the Odds
Thursday, Jan. 28
6:30-8:30 PM
CE Credits: 2
Cost: Free for WSDA Members
| • |
This course will be presented via live Zoom webinar.
|
| • |
Please note that registration is first-come, first-served, with a 1,000-person maximum.
|
| • |
The registration deadline is Tuesday, Jan. 26.
|
| • |
In order to earn CE credit, attendees must join using a computer, laptop, or smart device. Those only calling in by phone will not be eligible for CE credit. |
By the time the FDA approved articaine in the US, dentists in a European country with a population of more than 80 million were already very familiar with its abilities. Recent evidence significantly raises the ante.
More popular in medicine perhaps because of the simplicity of their formulations, some specific drug combinations demonstrated superior effectiveness compared with vasoconstrictor-containing local anesthetics currently available in dental cartridges.
While every FDA-approved dental LA drug has its indications, in the specific situations and challenges in which these two agents demonstrated greater effectiveness, they did so with wide margins of superiority. Their adoption does not guarantee success every time of course (LA is estimated to fail about 10% of the time, across all disciplines), but these two agents are often capable of avoiding and/or reversing downhill slides. Even in their absence, however, there are modifications to common strategies capable of accomplishing similar outcomes. A simple case will highlight the drugs and strategies, as well as the rationale behind the strategies.
Participants can look forward to learning why, how, and when the two drugs and some specific modifications are capable of increasing the odds of success.
Learn More and Register
|
|
|
|
|
|
|
